✓ Enriched with full company details from live data.
Origin Biosciences, a subsidiary of BridgeBio Pharma, is a biotechnology company focused treatment for Molybdenum Cofactor Deficiency (MoCD). Origin is led by a team of veteran biotechnology executives. Together with patients and physicians, the company ai
Technology stack
Click any tool to see other companies using it.
AIAmazon AWSCircleDigitalOceanElasticEmailGoogle AnalyticsGoogle Tag ManagerMicrosoft Office 365MimecastMobile FriendlyNginxOutlookRackspace MailGunRemoteRenderTypekitWordPress.orgreCAPTCHA
🔥 1 person from Origin Biosciences is searchable on evyAI — names, titles, and unlockable contact info.
Also appears in these lists
- Top 100 Biotechnology Research in the United States — 9,440 companies
- Top 100 Companies Using ElasticEmail — 29,219 companies